Annual D&A
$2.06M$771.00K+59.67%
Summary
- Current Value
- As of today, ARDX annual D&A is $2.06M, up +59.67% on
- Historical Performance
- ARDX annual D&A is down -26.51% over the past 3 years, and down -17.51% over the past 5 years
- All-Time High Comparison
- ARDX annual D&A is currently -26.51% below its historical high of $2.81M set on
- 3-Year Low Comparison
- ARDX annual D&A is +80.33% above its 3-year low of $1.14M reached on an earlier date
- Sector Comparison
- ARDX annual D&A is higher than 51.43% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $2.06M | +59.7% | -26.5% | -17.5% | +205.6% | |
| Quarterly D&A | $905.00K | +66.4% | -39.7% | -7.8% | +414.2% | |
| TTM D&A | $2.65M | +440.1% | -42.7% | -50.1% | +1407.4% | |
| Price | $7.94 | +44.0% | +149.5% | +9.9% | – | |
| Annual SG&A | $258.69M | +92.5% | +257.8% | +966.0% | +6317.6% | |
| Annual Total Expenses | $361.57M | +92.6% | +119.9% | +274.5% | +2443.6% | |
| Annual Operating Expenses | $311.01M | +83.0% | +90.3% | +224.2% | +2087.9% | |
| Annual Revenue | $333.62M | +168.1% | +3204.1% | +6217.3% | +6066.6% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.06M | at high | |
| 5Y | $2.81M | -26.5% | |
| All | $2.81M | -26.5% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.14M | N/A | +80.3% |
| 5Y | $1.14M | +80.3% | |
| All | $302.00K | +583.1% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of ARDX?
As of today, ARDX annual D&A is $2.06M
What is 1-year change in ARDX annual D&A?
ARDX annual D&A is up +59.67% year-over-year
What is 3-year change in ARDX annual D&A?
ARDX annual D&A is down -26.51% over the past 3 years
How far is ARDX annual D&A from its all-time high?
ARDX annual D&A is currently -26.51% below its historical high of $2.81M set on December 31, 2021
How does ARDX annual D&A rank versus sector peers?
ARDX annual D&A is higher than 51.43% of companies in Healthcare sector
When is ARDX next annual earnings release?
The next annual earnings release for ARDX is on
Quarterly D&A
$905.00K$274.00K+43.42%
Summary
- Current Value
- As of today, ARDX quarterly D&A is $905.00K, up +43.42% on
- Historical Performance
- ARDX quarterly D&A is up +66.36% year-over-year, and down -39.67% over the past 3 years
- All-Time High Comparison
- ARDX quarterly D&A is currently -61.44% below its historical high of $2.35M set on
- 3-Year Low Comparison
- ARDX quarterly D&A is +138.87% above its 3-year low of -$2.33M reached on
- Sector Comparison
- ARDX quarterly D&A is higher than 57.23% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $905.00K | +43.4% | +66.4% | -39.7% | -7.8% | |
| Annual D&A | $2.06M | – | +59.7% | -26.5% | -17.5% | |
| TTM D&A | $2.65M | +15.8% | +440.1% | -42.7% | -50.1% | |
| Price | $7.94 | +56.8% | +44.0% | +149.5% | +9.9% | |
| Quarterly SG&A | $83.61M | -0.5% | +28.7% | +347.9% | +995.3% | |
| Quarterly Total Expenses | $111.30M | -4.7% | +12.4% | +299.2% | +434.6% | |
| Quarterly Operating Expenses | $100.77M | +1.8% | +26.4% | +309.1% | +487.2% | |
| Quarterly Revenue | $110.33M | +13.0% | +12.3% | +2112.8% | +3966.7% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $905.00K | at high | |
| 3Y | $1.56M | -42.0% | |
| 5Y | $1.56M | -42.0% | |
| All | $2.35M | -61.4% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $515.00K | N/A | +75.7% |
| 3Y | -$2.33M | +138.9% | |
| 5Y | -$2.33M | +138.9% | |
| All | -$2.33M | +138.9% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of ARDX?
As of today, ARDX quarterly D&A is $905.00K
What is ARDX quarterly D&A most recent change?
ARDX quarterly D&A was up +43.42% on September 30, 2025
What is 1-year change in ARDX quarterly D&A?
ARDX quarterly D&A is up +66.36% year-over-year
How far is ARDX quarterly D&A from its all-time high?
ARDX quarterly D&A is currently -61.44% below its historical high of $2.35M set on December 31, 2019
How does ARDX quarterly D&A rank versus sector peers?
ARDX quarterly D&A is higher than 57.23% of companies in Healthcare sector
When is ARDX next earnings release?
The next earnings release for ARDX is on
TTM D&A
$2.65M$361.00K+15.75%
Summary
- Current Value
- As of today, ARDX TTM D&A is $2.65M, up +15.75% on
- Historical Performance
- ARDX TTM D&A is up +440.13% year-over-year, and down -42.66% over the past 3 years
- All-Time High Comparison
- ARDX TTM D&A is currently -50.08% below its historical high of $5.31M set on
- 3-Year Low Comparison
- ARDX TTM D&A is +440.13% above its 3-year low of -$780.00K reached on
- Sector Comparison
- ARDX TTM D&A is higher than 52.93% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $2.65M | +15.8% | +440.1% | -42.7% | -50.1% | |
| Annual D&A | $2.06M | – | +59.7% | -26.5% | -17.5% | |
| Quarterly D&A | $905.00K | +43.4% | +66.4% | -39.7% | -7.8% | |
| Price | $7.94 | +56.8% | +44.0% | +149.5% | +9.9% | |
| TTM SG&A | -$3.70B | -1301.6% | -1707.8% | -5229.9% | -10000.0% | |
| TTM Revenue | $398.23M | +3.1% | +58.1% | +4320.4% | +4870.5% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.65M | at high | |
| 3Y | $4.96M | -46.5% | |
| 5Y | $4.96M | -46.5% | |
| All | $5.31M | -50.1% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.06M | N/A | +28.6% |
| 3Y | -$780.00K | +440.1% | |
| 5Y | -$780.00K | +440.1% | |
| All | -$780.00K | +440.1% |
TTM D&A History
FAQ
What is the current TTM D&A of ARDX?
As of today, ARDX TTM D&A is $2.65M
What is ARDX TTM D&A most recent change?
ARDX TTM D&A was up +15.75% on September 30, 2025
What is 1-year change in ARDX TTM D&A?
ARDX TTM D&A is up +440.13% year-over-year
How far is ARDX TTM D&A from its all-time high?
ARDX TTM D&A is currently -50.08% below its historical high of $5.31M set on September 30, 2020
How does ARDX TTM D&A rank versus sector peers?
ARDX TTM D&A is higher than 52.93% of companies in Healthcare sector
When is ARDX next earnings release?
The next earnings release for ARDX is on
Data Sources & References
- ARDX Official Website www.ardelyx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1437402/000143740225000018/0001437402-25-000018-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1437402/000162828025006653/0001628280-25-006653-index.htm
- ARDX Profile on Yahoo Finance finance.yahoo.com/quote/ARDX
- ARDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ardx